Advances in the molecular modeling and quantitative structure–activity relationship-based design for antihistamines

Author： Galvez Jorge Galvez-Llompart Maria Zanni Riccardo Garcia-Domenech Ramon

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.3, 2013-03, pp. : 305-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in quantitative structure–activity relationship models of antimalarials

By Roy Kunal Ojha Probir Kumar

Expert Opinion on Drug Discovery, Vol. 5, Iss. 8, 2010-08 ,pp. : 751-778

Informa Healthcare

Access to resources Recommend Favorite

Advances in quantitative structure–activity relationship models of antioxidants

By Roy Kunal Mitra Indrani

Expert Opinion on Drug Discovery, Vol. 4, Iss. 11, 2009-11 ,pp. : 1157-1175

Informa Healthcare

Access to resources Recommend Favorite

Advances in quantitative structure–activity relationship models of anti-Alzheimer’s agents

By Ambure Pravin Roy Kunal

Expert Opinion on Drug Discovery, Vol. 9, Iss. 6, 2014-06 ,pp. : 697-723

Informa Healthcare

Access to resources Recommend Favorite

The Discovery of Novel Histone Lysine Methyltransferase G9a Inhibitors (Part 1): Molecular Design Based on a Series of Substituted 2,4-Diamino-7- aminoalkoxyquinazoline by Molecular-Docking-Guided 3D Quantitative Structure-Activity Relationship Studies

Medicinal Chemistry, Vol. 10, Iss. 4, 2014-04 ,pp. : 426-440

Bentham Science Publishers

Access to resources Recommend Favorite

Quantitative Structure-Activity Relationship Studies on Cholecystokinin Antagonists

Current Pharmaceutical Design, Vol. 8, Iss. 2, 2002-01 ,pp. : 111-124

Bentham Science Publishers

Access to resources Recommend Favorite